Abstract:Tanshinone IIA (Tan IIA), one of the major active constituents of the medicinal herb Salvia miltiorrhiza, has been reported to possess neuroprotective effects against the pathological features of Alzheimer's disease (AD), but the molecular mechanism underlying this effect remains unclear. To examine the effect of Tan IIA on AD, as well as the underlying molecular mechanisms, in vivo animal experiments and in vitro molecular biology investigations were employed in the present study. Firstly, a rat model of AD was successfully established by direct injection of the amyloid beta protein (A beta) and then these rats were administered an interventional treatment of Tan IIA. The learning and memory ability of rats was evaluated in four groups (Control, Sham, AD and Tan IIA) utilizing a Morris water maze test. Quantitative (q)PCR was employed to detect the mRNA expression of inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2) and nuclear transcription factor kappa (NF-kappa Bp65) in temporal lobe tissues and protein expression was determined with western blot analysis. In addition, association analyses between iNOS, MMP-2 and NF-kappa Bp65 at a transcriptional and translational level were performed utilizing Spearman's correlation analysis. In the present study, the results revealed that rats in the AD group demonstrated significant disruptions in learning and memory ability, and the symptoms were evidently reduced by Tan IIA. Furthermore, the upregulation of iNOS, MMP-2 and NF-kappa Bp65 at a transcriptional and translational level in AD rats was distinctly inhibited by Tan IIA. Therefore, it was concluded that iNOS, MMP-2 and NF-kappa Bp65 are involved in AD development, and Tan IIA may reduce AD risk by inhibiting transcription and translation of these genes. Furthermore, the positive correlation of iNOS and MMP-2 with NF-kappa Bp65, respectively, provides evidence supporting the hypothesis that Tan IIA reduces AD risk by inhibiting iNOS and MMP-2 at a transcriptional and translational level through the NF-kappa B pathway. In summary, Tan HA is an effective neuroprotective agent for AD therapy, and iNOS, MMP-2 and NF-kappa Bp65 may be the potential molecular targets for manipulating this effect therapeutically.

Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β 1-42 Induced Alzherimer's Disease Rat Model using UHPLC-Q-Exactive Qrbitrap Mass Spectrometry.

STUDY ON METABONOMICS MECHANISM OF COMPATIBILITY OF GINSENOSIDES AND TENUIGENINS ON ALZHEIMER’S DISEASE RATS BASED ON UPLC-MS

The Protective Effects of Tanshinone IIA on Neurotoxicity Induced by Β-Amyloid Protein Through Calpain and the P35/cdk5 Pathway in Primary Cortical Neurons.

Study On Urine Metabolic Profile Of A Beta 25-35-Induced Alzheimer'S Disease Using Uhplc-Q-Tof-Ms

Tanshinone IIA protects PC12 cells from β-amyloid-induced apoptosis via PI3K/Akt signaling pathway

Dihydrotanshinone I Increase Amyloid-β Clearance and Decrease Tau Phosphorylation via Enhancing Autophagy

Tanshinone IIA protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway

Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice

Tanshinone IIA Reduces the Risk of Alzheimer’s Disease by Inhibiting Inos, MMP-2 and NF-κBp65 Transcription and Translation in the Temporal Lobes of Rat Models of Alzheimer’s Disease

The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons.

Tanshinone IIA protects PC12 cells from β-amyloid 25–35 -induced apoptosis via PI3K/Akt signaling pathway

Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway

The Protective Effects of TanIIA on Neurotoxicity Induced by Β-Amyloid Protein Through the Cdk5/P35 Pathway in Cultured Primary Neurons

Multi-factor Combined Biomarker Screening Strategy to Rapidly Diagnose Alzheimer's Disease and Evaluate Drug Effect Based on a Rat Model

Investigation of Plasma Metabolomics and Neurotransmitter Dysfunction in the Process of Alzheimer's Disease Rat Induced by Amyloid Beta 25-35

Tanshinone IIA improves Alzheimer’s disease via RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis

Rapid HPLC-ESI-MS/MS Analysis of Neurotransmitters in the Brain Tissue of Alzheimer’s Disease Rats before and after Oral Administration of Xanthoceras sorbifolia Bunge

Tanshinone IIA Regulates Glycogen Synthase Kinase-3Β-related Signaling Pathway and Ameliorates Memory Impairment in APP/PS1 Transgenic Mice.

Design, Synthesis, and Bioactivity of Novel Bifunctional Small Molecules for Alzheimer's disease.

UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer’s disease cell model induced by Aβ 1–42